Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Curemark Llc patents


Recent patent applications related to Curemark Llc. Curemark Llc is listed as an Agent/Assignee. Note: Curemark Llc may have other listings under different names/spellings. We're not affiliated with Curemark Llc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Curemark Llc-related inventors


Method of treating proteinuria in pregnancy

A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and a method for preparing the therapeutic agent are disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. ... Curemark Llc

Methods and compositions for the treatment of symptoms of prion diseases

A therapeutic composition for the treatment of the symptoms of prion diseases and the method for preparing the therapeutic agents is disclosed. The therapeutic composition is a stable pharmaceutical composition comprising one or more digestive and/or pancreatic enzymes. ... Curemark Llc

Methods and compositions for the treatment of symptoms of complex regional pain syndrome

A therapeutic composition for the treatment of the symptoms of complex regional pain syndrome and the method for preparing the therapeutic agents is disclosed. The therapeutic composition is a stable pharmaceutical composition comprising one or more digestive and/or pancreatic enzymes. ... Curemark Llc

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

A therapeutic agent for the treatment of the symptoms of addiction and the method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. ... Curemark Llc

Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders

A pharmaceutical preparation for the treatment of attention deficit disorders combines a therapeutically effective amount of digestive enzymes, such as chymotrypsin, and medication used to treat attention deficit disorders, such as ritalin®, concerta®, adderall® and strattera®. The preparation may be in the form of a tablet, capsule or time released formula in order to reduce the amount of pills per dosage. ... Curemark Llc

Methods and compositions for the prevention and treatment of influenza

This disclosure relates to the prevention and treatment of influenza, and more particularly influenza a virus subtype h1n1, with the use of a pharmaceutical composition comprising one or more digestive enzymes, such as pancreatic enzymes and porcine pancreatic enzymes. The disclosure further relates to the use of an individual's fecal chymotrypsin level as an indicator, e.g., biomarker of whether an individual may be more susceptible to influenza, e.g., influenza a subtype h1n1, and/or whether an individual will benefit from administration of the described pharmaceutical compositions. ... Curemark Llc

Method of treatment of schizophreniform disorder

Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for treating an individual with a neuropsychiatric disorder using digestive enzymes and their derivatives to alleviate the symptoms of neuropsychiatric disorders. ... Curemark Llc

Method for treating pervasive development disorders

A method of utilizing the chymotrypsin level of an individual as a measure of the success of secretin, other neuropeptides, and peptides or digestive enzyme administration to such individuals, and in particular, as a prognosticative of potential secretin, other neuropeptides, peptides, and digestive enzyme administration for persons having add, adhd, autism and other pdd related disorders. In one aspect, a method for determining the efficacy of secretin, other neuropeptides, peptides, or digestive enzymes for the treatment of an individual diagnosed with a pervasive developmental disorder (pdd) comprises obtaining a sample of feces from an individual, determining a quantitative level of chymotrypsin present in the sample, and correlating the quantitative level of chymotrypsin determined to be present in the sample with the pdd to determine the efficacy of treating the individual with secretin, other neuropeptides, peptides, or digestive enzyme administration. ... Curemark Llc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Curemark Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Curemark Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###